Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Takeda

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 9, 2005
Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchangerHikaru Tanaka, Iyuki Namekata, Kentaro Takeda, et al.
Japanese Journal of Clinical Oncology|March 30, 2012
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancerSeiichiro Ozono, Takeshi Ueda, Senji Hoshi, et al.
Scientific Reports|January 26, 2026
Impact of symptomatic comorbidities on heatstroke outcomes: A retrospective nationwide cohort studyKoichi Inukai, Ryo Narikawa, Suguru Kishitani, et al.
Journal of Pharmacological Sciences|February 9, 2007
Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heartAkira Takahara, Hideki Nakamura, Hideaki Nouchi, et al.
Drugs in R&D|December 17, 2020
Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I StudyAkira Ono, Haruyasu Murakami, Takashi Seto, et al.
Heartrhythm Case Reports|February 24, 2026
Transient bradycardia-dependent pacing threshold elevation in the early phase after atrial leadless pacemaker implantationYu Ishihara, Takahisa Noma, Masaki Takeuchi, et al.
Nature Communications|May 6, 2016
The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
Investigational New Drugs|May 2, 2019
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignanciesNoboru Yamamoto, Baek-Yeol Ryoo, Bhumsuk Keam, et al.
Nature Communications|August 22, 2017
Corrigendum: The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
International Journal of Clinical Oncology|January 23, 2016
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancerHideyuki Akaza, Hirotsugu Uemura, Taiji Tsukamoto, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 9, 2005
Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchangerHikaru Tanaka, Iyuki Namekata, Kentaro Takeda, et al.
Japanese Journal of Clinical Oncology|March 30, 2012
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancerSeiichiro Ozono, Takeshi Ueda, Senji Hoshi, et al.
Scientific Reports|January 26, 2026
Impact of symptomatic comorbidities on heatstroke outcomes: A retrospective nationwide cohort studyKoichi Inukai, Ryo Narikawa, Suguru Kishitani, et al.
Journal of Pharmacological Sciences|February 9, 2007
Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heartAkira Takahara, Hideki Nakamura, Hideaki Nouchi, et al.
Drugs in R&D|December 17, 2020
Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I StudyAkira Ono, Haruyasu Murakami, Takashi Seto, et al.
Heartrhythm Case Reports|February 24, 2026
Transient bradycardia-dependent pacing threshold elevation in the early phase after atrial leadless pacemaker implantationYu Ishihara, Takahisa Noma, Masaki Takeuchi, et al.
Nature Communications|May 6, 2016
The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
Investigational New Drugs|May 2, 2019
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignanciesNoboru Yamamoto, Baek-Yeol Ryoo, Bhumsuk Keam, et al.
Nature Communications|August 22, 2017
Corrigendum: The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
International Journal of Clinical Oncology|January 23, 2016
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancerHideyuki Akaza, Hirotsugu Uemura, Taiji Tsukamoto, et al.
Pageof 7